ClinicalTrials.gg

Program

TB006

Its studies are mostly in Alzheimer Disease · Parkinson Disease · Ischemic Stroke · COVID-19, led by TrueBinding.

Furthest: phase 2, since Sep 24, 20216 company-led studies, 1 open or runningNext primary completion: Nov 28, 2026 (phase 2)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
TrueBinding61 open or runningphase 2since Sep 24, 2021Mar 11, 2021Nov 28, 2026phase 2 · NCT06773962

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Mar 11, 2021First study: phase 1 study in COVID-19First studyNCT04801056
  2. May 18, 2021Phase 1 study in Alzheimer DiseaseNCT04920786 · 48 enrolled · United States
  3. Sep 24, 2021Phase 2 study in Alzheimer DiseaseNCT05074498 · 154 enrolled · United States
  4. Dec 1, 2021Phase 2 study in Ischemic StrokeNCT05156827
  5. Jul 25, 2022Phase 2 study in Alzheimer DiseaseNCT05476783 · 119 enrolled · United States
  6. Jan 8, 2025Phase 2 study in Parkinson DiseaseNCT06773962 · 62 enrolled · United States

Ahead

  1. Nov 28, 2026Primary completion: phase 2 study in Parkinson DiseaseNCT06773962

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 6 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT06773962Parkinson Disease · United States2Active, not recruitingNov 28, 202662
NCT05476783Alzheimer Disease · United States2TerminatedNov 17, 2023119
NCT05156827Ischemic Stroke2WithdrawnDec 18, 20230
NCT05074498Alzheimer Disease · United States2CompletedOct 13, 2022154
NCT04920786Alzheimer Disease · United States1CompletedMay 3, 202248
NCT04801056COVID-191WithdrawnSep 1, 20210

How it is read

Names in the registry

  • “TB006”, 6 entries

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.